In vivo Neurochemistry with PET, SPECT and MRI
The use of novel methods in positron emission tomography (PET) and single photon emission computed tomography (SPECT) have, in the past few decades, been used to study a wide variety of neuropsychiatric illness, basic brain chemistry and pharmacology. Our focus is on the design, development and application of radiopharmaceuticals imaged PET and SPECT for the study of in vivo brain chemistry. Our research extends from collaborations in basic chemistry through pharmacology, imaging of small and large animals and healthy human subjects as well as the study of volunteers with neuropsychiatric illness.
Current projects in our laboratory include PET/MRI studies in Tourette’s Syndrome, dementia, alcoholism, cocaine abuse, schizophrenia, as well as the discovery and development of CNS drugs. We also collaborate on several small animal imaging studies on Alzheimer’s, Rett’s Syndrome, ADHD, obesity. Our lab does most of our PET research on the high resolution research tomograph (HRRT), one of only 15 scanners of the highest resolution for brain imaging (2-3 mm) in the world and associated high end computing clusters. We do our research with approximately 15 scientists, mathematical modelers, chemists, psychologists, psychiatrists and nuclear medicine physicians.
We also host a Joint seminar for the Section of High Resolution Brain PET ( Nuc Med /Radiology) and Brain Sciences Imaging Core, on Wednesdays from 1pm to 2 pm. For additional information please contact: Dean F Wong MD PhD email@example.com or Arman Rahmim PhD firstname.lastname@example.org.